Legend Biotech Corp (LEGN) Payables (2019 - 2024)
Legend Biotech (LEGN) has disclosed Payables for 6 consecutive years, with $38.6 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Payables rose 25.9% year-over-year to $38.6 million, compared with a TTM value of $38.6 million through Dec 2024, up 25.9%, and an annual FY2024 reading of $38.6 million, up 25.9% over the prior year.
- Payables was $38.6 million for Q4 2024 at Legend Biotech, up from $30.7 million in the prior quarter.
- Across five years, Payables topped out at $38.6 million in Q4 2024 and bottomed at $4.9 million in Q4 2020.
- Average Payables over 5 years is $22.8 million, with a median of $30.7 million recorded in 2023.
- The sharpest move saw Payables tumbled 48.77% in 2020, then skyrocketed 367.03% in 2022.
- Year by year, Payables stood at $4.9 million in 2020, then surged by 43.41% to $7.0 million in 2021, then surged by 367.03% to $32.9 million in 2022, then fell by 6.8% to $30.7 million in 2023, then grew by 25.9% to $38.6 million in 2024.
- Business Quant data shows Payables for LEGN at $38.6 million in Q4 2024, $30.7 million in Q4 2023, and $32.9 million in Q4 2022.